• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

International Alliance

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Favorite Forum Topics

  • Oh, bother! No topics were found here.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition and Swallowing
  • Occupational Therapy and Activities of Daily Living
  • Physiotherapy and Mobility
  • Respiratory Care
  • Speech Therapy and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Events/Programs

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Newsletters
    • Meetings
  • Awards

Upcoming Events

Sep 22
2:00 pm - 3:00 pm EDT

ALS Association Webinar: Affordable Tools for Everyday Independence

Sep 23
1:00 pm - 2:00 pm EDT

ALS Canada Webinar: Navigating Grief While Living with ALS

Sep 24
1:00 pm - 2:00 pm EDT

Les Turner ALS Foundation: Cognitive and Language Impairments in ALS & ALS-FTD

Oct 13
8:00 am - 9:00 am EDT

Member Forum: Technology Solutions for PALS

Oct 13
6:00 pm - 7:00 pm EDT

Member Forum: Technology Solutions for PALS

View Calendar

  • Charlie Dourney, USA

    Charlie Dourney, USA

  • Rudiger Hanemann, Germany

    Rudiger Hanemann, Germany

  • Lucy Lintott, Scotland

    Lucy Lintott, Scotland

  • Duncan Bayly, Australia

    Duncan Bayly, Australia

  • Soledad Rodriguez, Spain

    Soledad Rodriguez, Spain

  • Angela Jansen, Germany

    Angela Jansen, Germany

  • Shaleen Latchman, Canada

    Shaleen Latchman, Canada

  • Timothy Holman, Switzerland

    Timothy Holman, Switzerland

  • Jose Rivero Muñoz, Mexico

    Jose Rivero Muñoz, Mexico

  • Mike Small, UK

    Mike Small, UK

  • Ian Gale, Australia

    Ian Gale, Australia

  • Shay Rishoni, Netherlands

    Shay Rishoni, Netherlands

  • Ali Var, Turkey

    Ali Var, Turkey

  • Liong Ting Ngu, Malaysia

    Liong Ting Ngu, Malaysia

  • Jorge Melo, Brazil

    Jorge Melo, Brazil

  • Jason Goodman, USA

    Jason Goodman, USA

  • Guido De Mets, Belgium

    Guido De Mets, Belgium

  • Claudette Sturk, Canada

    Claudette Sturk, Canada
    Picture2

  • Claudia Cominetti, Italy

    Claudia Cominetti, Italy

  • Danny Reviers, Belgium

    Danny Reviers, Belgium

  • Jorge Luis Fernández Romero, Mexico

    Jorge Luis Fernández Romero, Mexico

  • Christian Bär, Germany

    Christian Bär, Germany

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Ali Var, Turkey

    Ali Var, Turkey

  • Jeff Sutherland, Canada

    Jeff Sutherland, Canada
    jspic

  • Joanne Pratt, Australia

    Joanne Pratt, Australia

  • John Russo, USA

    John Russo, USA
    final3878

  • Armando González Gómez, Colombia

    Armando González Gómez, Colombia

  • Antonio Ventriglia, Belgium

    Antonio Ventriglia, Belgium

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Nicholas (Nic) Bowman, South Africa

    Nicholas (Nic) Bowman, South Africa

  • Shera Mukherjee, India

    Shera Mukherjee, India

  • Frank Bos, Netherlands

    Frank Bos, Netherlands

  • Phil Rossall, UK

    Phil Rossall, UK

  • Xian-Zhang Niu, China

    Xian-Zhang Niu, China

  • Purningam Jacob, India

    Purningam Jacob, India

  • Wiebke Braach, Germany

    Wiebke Braach, Germany

  • Federica Mastrosimone, Italy

    Federica Mastrosimone, Italy

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • PALS and CALS, Singapore

    PALS and CALS, Singapore

  • Bruno Leanza Mantegna, Italy

    Bruno Leanza Mantegna, Italy

  • Fabio Correia, Brazil

    Fabio Correia, Brazil

  • Den Haag, Netherlands

    Den Haag, Netherlands

  • Fabrice Kamp, Germany

    Fabrice Kamp, Germany

  • Lombana, Spain

    Lombana, Spain

  • Jette Odgaard Villemoes, Denmark

    Jette Odgaard Villemoes, Denmark

  • Cath Muir, UK

    Cath Muir, UK
    Cath

  • Orly Dichoso, Canada

    Orly Dichoso, Canada

  • Yannick Richard, Canada

    Yannick Richard, Canada
    yannickrichard

  • Kris Van Reusel, Belgium

    Kris Van Reusel, Belgium

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login